Pharmacogenomics and artificial intelligence in cardiovascular disease: emerging tools for precision medicine.
Cardiovascular diseases (CVD) remain a predominant cause of mortality and morbidity globally. Conventional therapy methods may be constrained by their inadequate acknowledgment of individual genetic and clinical variations.
Cardiovascular diseases (CVD) remain a predominant cause of mortality and morbidity globally. Conventional therapy methods may be constrained by their inadequate acknowledgment of individual genetic and clinical variations.
What the study was
- Study design
- Review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Pharmacogenomics
Why it surfaced
Matched watchlist topic 'AI/ML in clinical diagnostics and imaging'. Study design: Review. Score: 8/10 (N:3, R:3, D:1, P:1).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.